Your search returned 74 results.

Sort
Results
61.
62.
63.
64.
65.
66.
67.
68.
69.
Cerebrospinal fluid and blood biomarkers for neurodegenerative dementias: An update of the Consensus of the Task Force on Biological Markers in Psychiatry of the World Federation of Societies of Biological Psychiatry. [electronic resource] by
Producer: 20180926 In: The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry vol. 19
Availability: No items available.

70.
Prevalence of the apolipoprotein E ε4 allele in amyloid β positive subjects across the spectrum of Alzheimer's disease. [electronic resource] by
Producer: 20190809 In: Alzheimer's & dementia : the journal of the Alzheimer's Association vol. 14
Availability: No items available.

71.
Correction to: A nonsynonymous mutation in PLCG2 reduces the risk of Alzheimer's disease, dementia with Lewy bodies and frontotemporal dementia, and increases the likelihood of longevity. [electronic resource] by
Publication details: Acta neuropathologica 05 2020
In: Acta neuropathologica vol. 139
Availability: No items available.

72.
A nonsynonymous mutation in PLCG2 reduces the risk of Alzheimer's disease, dementia with Lewy bodies and frontotemporal dementia, and increases the likelihood of longevity. [electronic resource] by
Producer: 20200720 In: Acta neuropathologica vol. 138
Availability: No items available.

73.
Association of Cerebral Amyloid-β Aggregation With Cognitive Functioning in Persons Without Dementia. [electronic resource] by
Producer: 20190912 In: JAMA psychiatry vol. 75
Availability: No items available.

74.
Prevalence of cerebral amyloid pathology in persons without dementia: a meta-analysis. [electronic resource] by
Producer: 20150522 In: JAMA vol. 313
Availability: No items available.